Arcturus Therapeutics In...

NASDAQ: ARCT · Real-Time Price · USD
19.48
0.25 (1.30%)
At close: Aug 15, 2025, 3:59 PM
19.17
-1.62%
After-hours: Aug 15, 2025, 07:54 PM EDT

Arcturus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-80.94M -29.73M 9.35M -203.67M
Depreciation & Amortization
3.54M 2.96M 1.53M 1.19M
Stock-Based Compensation
37.99M 34.65M 30.61M 28.91M
Other Working Capital
-50.81M 38.92M -10.05M 32.79M
Other Non-Cash Items
471K -33.36M 3.06M 8.38M
Deferred Income Tax
n/a n/a n/a -1.09M
Change in Working Capital
-20.81M 7.38M -12.56M 31.23M
Operating Cash Flow
-59.75M -18.1M 31.99M -135.04M
Capital Expenditures
-648K -2.9M -7.73M -3.41M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-648K -2.9M -7.73M -3.41M
Debt Repayment
n/a -27.36M -5M 46.6M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4.74M 2.67M 1.73M 902K
Financial Cash Flow
5.42M -24.09M -2.86M 48.02M
Net Cash Flow
-54.98M -45.09M 21.41M -90.43M
Free Cash Flow
-60.4M -21M 24.27M -138.45M